Advocating for Lung Cancer Patients
Lung cancer is the number one cancer killer in the U.S., but in the last few years, there has been tremendous hope and progress in finding new treatments. Help us continue to give new hope to Americans who are facing lung cancer. The American Lung Association advocates for much-needed resources and policies for the fight against lung cancer at federal, state and local levels. Your voice matters. Join us in raising much-needed awareness and funding for lung cancer.
What We're Doing
- We work to increase federal funding for lung cancer research, treatment and prevention programs conducted by the National Institutes of Health, Centers for Disease Control and Prevention, Department of Veterans Affairs, Department of Defense and other federal agencies.
- We advocate to ensure that people with lung cancer have quality and affordable healthcare—without worry about whether they will lose their coverage because of a pre-existing condition.
- We advocate for coverage of tobacco cessation treatments and life-saving lung cancer screening for those at high risk for developing the disease.
- The Lung Association also advocates for policies that will reduce the incidence of lung cancer by decreasing the number of Americans who smoke.
- At the federal level, a higher cigarette tax and strong, effective regulatory authority over tobacco products by the U.S. Food and Drug Administration, will help the number of smokers decline.
- At state and local levels, we fight for comprehensive smokefree indoor air laws and ordinances, higher cigarette taxes, and fully funded tobacco prevention and cessation programs.
- Radon is the second leading cause of lung cancer. For this reason, we lead a national coalition that works to build in systems that reduce radon exposure. We advocate for federal funding for radon education programs and detection.
Critical Need for Lung Cancer Research Funding
Research is the key to better early detection, improved treatments, longer survival and new hope for those facing lung cancer.
The good news is lung cancer research funding at the National Institutes of Health (NIH) is growing. Congress has markedly increased NIH's budget for cancer research—now funding a $300 million precision medicine increase on top of an estimated $360 million for lung cancer research in the fiscal year 2017.
This progress must be sustained and research funding must continue to grow. We're calling on the NIH to increase funding for lung cancer research from $331 million to $450 million by 2020, and Congress to continue to grow NIH's budget overall.
What You Can Do
Help us advocate for lifesaving policies to help all those impacted by lung cancer. Here are a few ways you can speak up and take action:
- Send a letter to your senators and representative to tell them you support funding for lifesaving research at the National Institutes of Health.
- Join our Lung Action Network to get notified of opportunities to contact your federal and state elected officials and other key decision makers.
- Get involved with LUNG FORCE, our movement to increase lung cancer awareness, promote research, advocate for critical funding and fight for the lives of those affected by lung cancer.
- Join the Lung Cancer Registry to share your lung cancer history and contribute to lung cancer research.
LUNG FORCE EventsLearn more
Lung Action NetworkLearn more
Approved by Scientific and Medical Editorial Review Panel. Last reviewed November 24, 2017.